Pasithea Therapeutics Statistics
Total Valuation
KTTA has a market cap or net worth of $5.37 million. The enterprise value is -$1.84 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KTTA has 7.44 million shares outstanding. The number of shares has increased by 132.08% in one year.
| Current Share Class | 7.44M |
| Shares Outstanding | 7.44M |
| Shares Change (YoY) | +132.08% |
| Shares Change (QoQ) | +155.12% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 11.04% |
| Float | 7.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.97
| Current Ratio | 4.97 |
| Quick Ratio | 4.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -85.84% and return on invested capital (ROIC) is -54.76%.
| Return on Equity (ROE) | -85.84% |
| Return on Assets (ROA) | -49.52% |
| Return on Invested Capital (ROIC) | -54.76% |
| Return on Capital Employed (ROCE) | -89.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.36M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.49% in the last 52 weeks. The beta is 0.27, so KTTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -80.49% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 1.09 |
| Relative Strength Index (RSI) | 44.73 |
| Average Volume (20 Days) | 84,390 |
Short Selling Information
The latest short interest is 22,916, so 0.31% of the outstanding shares have been sold short.
| Short Interest | 22,916 |
| Short Previous Month | 21,917 |
| Short % of Shares Out | 0.31% |
| Short % of Float | 0.31% |
| Short Ratio (days to cover) | 0.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.74M |
| Pretax Income | -13.46M |
| Net Income | -13.46M |
| EBITDA | -13.09M |
| EBIT | -13.74M |
| Earnings Per Share (EPS) | -$5.29 |
Full Income StatementBalance Sheet
The company has $7.22 million in cash and n/a in debt, giving a net cash position of $7.22 million or $0.97 per share.
| Cash & Cash Equivalents | 7.22M |
| Total Debt | n/a |
| Net Cash | 7.22M |
| Net Cash Per Share | $0.97 |
| Equity (Book Value) | 15.18M |
| Book Value Per Share | 2.04 |
| Working Capital | 6.90M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.49M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.49M |
| FCF Per Share | -$1.68 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
